The CYP2A6 gene polymorphism has been found to be associated with the development of lung cancer [37], and CYP2A6 has emerged as a novel candidate oncogene [38]; however, CYP2A6 amplification has not been investigated. The gene discussed is CYP2A6; the disease is lung cancer.